Chapters

1. 00:00 1 - Welcome - Jan Egberts
2. 02:18 2 - Strategic reflections - Erik Skullerud
3. 20:53 3 - Relapsed follicular lymphoma - evolving treatment algorithm and unmet medical need - Leo Gordon
4. 63:34 4 - Navigating the NHL landscape with betalutin - BEYOND the PARADIGME program - Pierre Dodion
5. 87:10 5 - Integrating targeted radioimmunotherapy in NHL care pathways - Marco Renoldi
6. 105:58 6 - The CMC journey to BLA and launch readiness - Lars Nieba
7. 119:42 7 - Nordic Nanovector pipeline, promising value-enhancing opportunities - Maureen Deehan
8. 144:13 8 - Humalutin - A CD37-targeted therapy for the treatment of Non Hodgkin Lymphoma - Jostein Dahle
9. 163:00 9 - Concluding remarks - Erik Skullerud
10. 166:02 Q & A